Pathophysiology Analysis of "Costello Syndrome" on Cellular Models
NCT02812511 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2016-06-24
Summary
The objective is to collect skin biopsies rom patients with Costello syndrome to analyze the molecular mechanisms responsible for this syndrome caused by a mutation in the HRAS gene and the effects of this mutation on energy metabolism and mitochondrial physiology.
Conditions
- Costello Syndrome
Interventions
- PROCEDURE
-
Biopsy
Skin biopsy is performed at the arm with a punch of 3 mm in diameter or a scalpel under local anesthesia, and then preserved in low glucose DMEM at room temperature.
Sponsors & Collaborators
-
University Hospital, Bordeaux
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 2 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2015-07-31
- Completion
- 2015-07-31
Countries
- France
Study Locations
More Related Trials
-
Prevalence and Characterization of Pain in RASopathies
NCT06355622 ·Status: RECRUITING ·Phase: NA
-
Study to Test Genetic Alterations Among Different Dermoscopic Types of Melanocytic Nevi.
NCT00422448 ·Status: COMPLETED ·Phase: NA
-
Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
NCT07015060 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1
NCT02680431 ·Status: UNKNOWN
-
Early Detection and Follow-Up of Patients With Fabry's Disease
NCT04847713 ·Status: UNKNOWN
-
Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.
NCT03211325 ·Status: COMPLETED ·Phase: NA
-
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
NCT06177353 ·Status: RECRUITING
-
Histiocytosis in Injecting Drug Users
NCT06573671 ·Status: ENROLLING_BY_INVITATION
-
Familial Systemic Scleroderma
NCT07343115 ·Status: RECRUITING
-
Study of in Vivo and in Vitro Transcriptomic and Proteomic Signatures in Unhereditary Ichtyosis
NCT05312073 ·Status: COMPLETED ·Phase: NA
-
Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
NCT02550080 ·Status: UNKNOWN ·Phase: PHASE4
-
Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking
NCT05532865 ·Status: RECRUITING
-
Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin
NCT03423004 ·Status: COMPLETED ·Phase: NA
-
Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
NCT05529134 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Pathophysiological Study of the Sensitive Scalp
NCT07156422 ·Status: RECRUITING ·Phase: NA
-
Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers
NCT00709631 ·Status: COMPLETED
-
Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders
NCT00895271 ·Status: ENROLLING_BY_INVITATION
-
Fibroblast Line Evaluation for COL5A eXpression and Thoracic Aortic Aneurysms: in Vitro Characterization of Cutaneous Fibroblasts in Adult Patients
NCT07282717 ·Status: NOT_YET_RECRUITING
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa
NCT04285294 ·Status: UNKNOWN
-
A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
NCT05979831 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT05732987 ·Status: RECRUITING
-
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
NCT01538862 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers in Systemic Histiocytosis
NCT07157683 ·Status: NOT_YET_RECRUITING
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED